Cover Image

Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals

In this review, we aim to explore the optimal approach to patients presenting with eosinophilia, considering recent advances in diagnostic and therapeutic strategies. Specifically, we focus on the integration of novel therapies into clinical practice to improve patient outcomes.

Saved in:
Bibliographic Details
Main Authors: Lübke, Johannes (Author) , Metzgeroth, Georgia (Author) , Reiter, Andreas (Author) , Schwaab, Juliana (Author)
Format: Article (Journal)
Language:English
Published: October 2024
In: Current hematologic malignancy reports
Year: 2024, Volume: 19, Issue: 5, Pages: 208-222
ISSN:1558-822X
DOI:10.1007/s11899-024-00738-7
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11899-024-00738-7
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s11899-024-00738-7
Get full text
Author Notes:Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, Juliana Schwaab

MARC

LEADER 00000caa a2200000 c 4500
001 1909081507
003 DE-627
005 20241205221741.0
007 cr uuu---uuuuu
008 241120s2024 xx |||||o 00| ||eng c
024 7 |a 10.1007/s11899-024-00738-7  |2 doi 
035 |a (DE-627)1909081507 
035 |a (DE-599)KXP1909081507 
035 |a (OCoLC)1475647739 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lübke, Johannes  |d 1996-  |e VerfasserIn  |0 (DE-588)1189769867  |0 (DE-627)1668483645  |4 aut 
245 1 0 |a Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals  |c Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, Juliana Schwaab 
264 1 |c October 2024 
300 |b Illustrationen 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 22. Juli 2024 
500 |a Gesehen am 20.11.2024 
520 |a In this review, we aim to explore the optimal approach to patients presenting with eosinophilia, considering recent advances in diagnostic and therapeutic strategies. Specifically, we focus on the integration of novel therapies into clinical practice to improve patient outcomes. 
650 4 |a CEL 
650 4 |a Eosinophilia 
650 4 |a HES 
650 4 |a Hypereosinophilia 
650 4 |a MLN-TK 
700 1 |a Metzgeroth, Georgia  |d 1972-  |e VerfasserIn  |0 (DE-588)1051897661  |0 (DE-627)786986832  |0 (DE-576)407534075  |4 aut 
700 1 |a Reiter, Andreas  |d 1964-  |e VerfasserIn  |0 (DE-588)172629551  |0 (DE-627)697563766  |0 (DE-576)133488594  |4 aut 
700 1 |a Schwaab, Juliana  |d 1982-  |e VerfasserIn  |0 (DE-588)1051912687  |0 (DE-627)787019399  |0 (DE-576)407558764  |4 aut 
773 0 8 |i Enthalten in  |t Current hematologic malignancy reports  |d Philadelphia, Pa. : Current Science, 2006  |g 19(2024), 5, Seite 208-222  |h Online-Ressource  |w (DE-627)534675549  |w (DE-600)2374151-X  |w (DE-576)306834618  |x 1558-822X  |7 nnas  |a Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals 
773 1 8 |g volume:19  |g year:2024  |g number:5  |g pages:208-222  |g extent:15  |a Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals 
856 4 0 |u https://doi.org/10.1007/s11899-024-00738-7  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s11899-024-00738-7  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241120 
993 |a Article 
994 |a 2024 
998 |g 1051912687  |a Schwaab, Juliana  |m 1051912687:Schwaab, Juliana  |d 60000  |d 61200  |e 60000PS1051912687  |e 61200PS1051912687  |k 0/60000/  |k 1/60000/61200/  |p 4  |y j 
998 |g 172629551  |a Reiter, Andreas  |m 172629551:Reiter, Andreas  |d 60000  |d 61200  |e 60000PR172629551  |e 61200PR172629551  |k 0/60000/  |k 1/60000/61200/  |p 3 
998 |g 1051897661  |a Metzgeroth, Georgia  |m 1051897661:Metzgeroth, Georgia  |d 60000  |d 61200  |e 60000PM1051897661  |e 61200PM1051897661  |k 0/60000/  |k 1/60000/61200/  |p 2 
998 |g 1189769867  |a Lübke, Johannes  |m 1189769867:Lübke, Johannes  |d 60000  |e 60000PL1189769867  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1909081507  |e 4617050175 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Online veröffentlicht: 22. Juli 2024","Gesehen am 20.11.2024"],"recId":"1909081507","name":{"displayForm":["Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, Juliana Schwaab"]},"relHost":[{"id":{"zdb":["2374151-X"],"issn":["1558-822X"],"eki":["534675549"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2006","publisher":"Current Science","publisherPlace":"Philadelphia, Pa.","dateIssuedDisp":"2006-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Current hematologic malignancy reports","title_sort":"Current hematologic malignancy reports"}],"part":{"pages":"208-222","text":"19(2024), 5, Seite 208-222","volume":"19","issue":"5","year":"2024","extent":"15"},"disp":"Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicalsCurrent hematologic malignancy reports","recId":"534675549","pubHistory":["1.2006 -"],"note":["Gesehen am 27.02.14"]}],"person":[{"role":"aut","given":"Johannes","family":"Lübke","display":"Lübke, Johannes"},{"role":"aut","given":"Georgia","family":"Metzgeroth","display":"Metzgeroth, Georgia"},{"role":"aut","family":"Reiter","display":"Reiter, Andreas","given":"Andreas"},{"role":"aut","display":"Schwaab, Juliana","family":"Schwaab","given":"Juliana"}],"physDesc":[{"noteIll":"Illustrationen","extent":"15 S."}],"title":[{"title":"Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals","title_sort":"Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"October 2024"}],"id":{"doi":["10.1007/s11899-024-00738-7"],"eki":["1909081507"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a LUEBKEJOHAAPPROACHTO2024 

Similar Items